-
公开(公告)号:US20080161374A1
公开(公告)日:2008-07-03
申请号:US12071038
申请日:2008-02-14
申请人: Hiroyuki Goto , Makoto Kakutani , Jun Nishiu , Yasuhiro Ohe , Jay P. Powers , Shinji Yata , Hua Tu
发明人: Hiroyuki Goto , Makoto Kakutani , Jun Nishiu , Yasuhiro Ohe , Jay P. Powers , Shinji Yata , Hua Tu
IPC分类号: A61K31/4184 , C07D231/10 , A61K31/415 , A61P43/00 , A61P3/10 , A61P3/04 , A61P3/00
CPC分类号: C07D231/12 , C07D401/04 , C07D401/06 , C07D401/08 , C07D401/10 , C07D401/14 , C07D403/10 , C07D405/04 , C07D413/10
摘要: Substituted pyrazoles are provided that are useful for the treatment of, for example, diabetes, obesity and metabolic syndrome.
摘要翻译: 提供了可用于治疗例如糖尿病,肥胖症和代谢综合征的取代的吡唑。
-
公开(公告)号:US07354938B2
公开(公告)日:2008-04-08
申请号:US11084734
申请日:2005-03-18
申请人: Hiroyuki Goto , Makoto Kakutani , Jun Nishiu , Yasuhiro Ohe , Jay P. Powers , Shinji Yata , Hua Tu
发明人: Hiroyuki Goto , Makoto Kakutani , Jun Nishiu , Yasuhiro Ohe , Jay P. Powers , Shinji Yata , Hua Tu
IPC分类号: A61K31/4439 , C07D401/04
CPC分类号: C07D231/12 , C07D401/04 , C07D401/06 , C07D401/08 , C07D401/10 , C07D401/14 , C07D403/10 , C07D405/04 , C07D413/10
摘要: Substituted pyrazoles are provided that are useful for the treatment of, for example, diabetes, obesity and metabolic syndrome.
-
公开(公告)号:US20070072908A1
公开(公告)日:2007-03-29
申请号:US11448980
申请日:2006-06-08
申请人: Hiroshi Yamamoto , Yasuhiro Ohe , Hiroyuki Goto , Kazuhito Harada , Shinji Yata , Takashi Ito , Jun Nishiu , Makoto Kakutani , Shunsuke Fujii , Kota Asahina
发明人: Hiroshi Yamamoto , Yasuhiro Ohe , Hiroyuki Goto , Kazuhito Harada , Shinji Yata , Takashi Ito , Jun Nishiu , Makoto Kakutani , Shunsuke Fujii , Kota Asahina
IPC分类号: A61K31/454 , C07D403/14
CPC分类号: C07D403/06 , C07D401/14 , C07D403/14 , C07D409/14 , C07D413/14 , C07D417/14
摘要: The present invention provides a compound represented by the following formula [1′] or a salt thereof: wherein ring A, R2, R3, R4 and X are as defined in the description, and an agent for the treatment or prophylaxis of a pathology involving glucocorticoid, or a 11βHSD1 inhibitor, containing the compound or a salt thereof.
摘要翻译: 本发明提供由下式[1']表示的化合物或其盐:其中环A,R 2,R 3,R 4, / SUP>和X如说明书中所定义,以及用于治疗或预防包含该化合物或其盐的糖皮质激素或11betaHSD1抑制剂的病理的药剂。
-
公开(公告)号:US20110245223A1
公开(公告)日:2011-10-06
申请号:US12958071
申请日:2010-12-01
申请人: Hiroshi Yamamoto , Yasuhiro Ohe , Hiroyuki Goto , Kazuhito Harada , Shinji Yata , Takashi Ito , Jun Nishiu , Makoto Kakutani , Shunsuke Fujii , Kota Asahina
发明人: Hiroshi Yamamoto , Yasuhiro Ohe , Hiroyuki Goto , Kazuhito Harada , Shinji Yata , Takashi Ito , Jun Nishiu , Makoto Kakutani , Shunsuke Fujii , Kota Asahina
IPC分类号: A61K31/4545 , C07D401/14 , A61K31/454 , C07D417/14 , A61K31/541 , A61K31/496 , C07D409/14 , A61K31/506 , A61K31/55 , C07D413/14 , A61K31/538 , C07C205/56 , C07C201/12 , C07D207/277 , C07D207/26 , C07D207/04 , A61P3/10 , A61P3/04 , A61P1/16 , A61P9/12 , A61P27/06 , A61P19/10 , A61P25/18 , A61P37/04
CPC分类号: C07D403/06 , C07D401/14 , C07D403/14 , C07D409/14 , C07D413/14 , C07D417/14
摘要: The present invention provides a compound represented by the following formula [1′] or a salt thereof: wherein ring A, R2, R3, R4 and X are as defined in the description, and an agent for the treatment or prophylaxis of a pathology involving glucocorticoid, or a 11βHSD1 inhibitor, containing the compound or a salt thereof.
摘要翻译: 本发明提供由下式[1']表示的化合物或其盐:其中环A,R 2,R 3,R 4和X如说明书中所定义,和用于治疗或预防涉及 糖皮质激素或含有该化合物或其盐的11βBBHSD1抑制剂。
-
公开(公告)号:US20050272793A1
公开(公告)日:2005-12-08
申请号:US11084734
申请日:2005-03-18
申请人: Hiroyuki Goto , Makoto Kakutani , Jun Nishiu , Yasuhiro Ohe , Jay Powers , Shinji Yata
发明人: Hiroyuki Goto , Makoto Kakutani , Jun Nishiu , Yasuhiro Ohe , Jay Powers , Shinji Yata
IPC分类号: A61K31/415 , C07D211/04 , C07D231/12 , C07D263/04 , C07D401/04 , C07D401/06 , C07D401/08 , C07D401/10 , C07D401/14 , C07D403/10 , C07D405/04 , C07D413/10
CPC分类号: C07D231/12 , C07D401/04 , C07D401/06 , C07D401/08 , C07D401/10 , C07D401/14 , C07D403/10 , C07D405/04 , C07D413/10
摘要: Substituted pyrazoles are provided that are useful for the treatment of, for example, diabetes, obesity and metabolic syndrome.
摘要翻译: 提供了可用于治疗例如糖尿病,肥胖症和代谢综合征的取代的吡唑。
-
-
-
-